Deskside with Dr. Dan
FDA approves Onureg (azacitidine tablets) for acute myeloid leukemia
In February 2021, the FDA announced the approval of Onureg, a new oral formulation of a drug used for remission continuation therapy in adults with acute myeloid leukemia (AML). Gryt Health Chief Medical Officer breaks this down for our community.
Gryt Health
September 15, 2022
